Packaged Foods
Compare Stocks
4 / 10Stock Comparison
PAVS vs TAOP vs CCSI vs LIQT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Industrial - Pollution & Treatment Controls
PAVS vs TAOP vs CCSI vs LIQT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Packaged Foods | Software - Infrastructure | Software - Infrastructure | Industrial - Pollution & Treatment Controls |
| Market Cap | $70K | $1M | $520M | $22M |
| Revenue (TTM) | $13M | $36M | $351M | $17M |
| Net Income (TTM) | $-27M | $-7M | $88M | $-9M |
| Gross Margin | 11.1% | 14.9% | 80.2% | 4.9% |
| Operating Margin | -10.3% | -15.7% | 42.9% | -50.0% |
| Forward P/E | 0.0x | — | 5.0x | — |
| Total Debt | $2M | $10M | $580M | $12M |
| Cash & Equiv. | $261K | $2M | $75M | — |
PAVS vs TAOP vs CCSI vs LIQT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Paranovus Entertain… (PAVS) | 100 | 0.0 | -100.0% |
| Taoping Inc. (TAOP) | 100 | 0.2 | -99.8% |
| Consensus Cloud Sol… (CCSI) | 100 | 79.4 | -20.6% |
| LiqTech Internation… (LIQT) | 100 | 5.3 | -94.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PAVS vs TAOP vs CCSI vs LIQT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PAVS is the clearest fit if your priority is value.
- Better valuation composite
TAOP lags the leaders in this set but could rank higher in a more targeted comparison.
CCSI is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 1 yrs, beta 1.51
- -20.6% 10Y total return vs LIQT's -90.9%
- Beta 1.51, current ratio 1.79x
- 25.1% margin vs PAVS's -211.2%
LIQT carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 13.0%, EPS growth 45.7%, 3Y rev CAGR 1.1%
- Lower volatility, beta 0.52
- 13.0% revenue growth vs PAVS's -98.9%
- Beta 0.52 vs TAOP's 2.30
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs PAVS's -98.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 25.1% margin vs PAVS's -211.2% | |
| Stability / Safety | Beta 0.52 vs TAOP's 2.30 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +64.8% vs PAVS's -99.9% | |
| Efficiency (ROA) | 13.2% ROA vs PAVS's -94.4%, ROIC 22.2% vs -27.1% |
PAVS vs TAOP vs CCSI vs LIQT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PAVS vs TAOP vs CCSI vs LIQT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCSI leads in 3 of 6 categories
PAVS leads 1 • TAOP leads 0 • LIQT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CCSI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CCSI is the larger business by revenue, generating $351M annually — 27.6x PAVS's $13M. CCSI is the more profitable business, keeping 25.1% of every revenue dollar as net income compared to PAVS's -2.1%. On growth, PAVS holds the edge at +180.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $36M | $351M | $17M |
| EBITDAEarnings before interest/tax | $531,773 | -$4M | $164M | -$6M |
| Net IncomeAfter-tax profit | -$27M | -$7M | $88M | -$9M |
| Free Cash FlowCash after capex | -$3M | -$3M | $112M | -$7M |
| Gross MarginGross profit ÷ Revenue | +11.1% | +14.9% | +80.2% | +4.9% |
| Operating MarginEBIT ÷ Revenue | -10.3% | -15.7% | +42.9% | -50.0% |
| Net MarginNet income ÷ Revenue | -2.1% | -19.6% | +25.1% | -53.3% |
| FCF MarginFCF ÷ Revenue | -23.5% | -8.1% | +32.0% | -39.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +180.3% | -2.6% | +1.5% | +53.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +76.9% | -51.7% | +21.5% | +69.4% |
Valuation Metrics
PAVS leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $70,061 | $1M | $520M | $22M |
| Enterprise ValueMkt cap + debt − cash | $2M | $9M | $1.0B | $34M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.16x | 6.50x | -2.59x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.00x | — | 4.99x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 6.07x | — |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 0.04x | 1.49x | 1.35x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.08x | 39.95x | 2.14x |
| Price / FCFMarket cap ÷ FCF | — | — | 4.92x | — |
Profitability & Efficiency
CCSI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CCSI delivers a 52.9% return on equity — every $100 of shareholder capital generates $53 in annual profit, vs $-116 for PAVS. PAVS carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCSI's 42.14x. On the Piotroski fundamental quality scale (0–9), PAVS scores 5/9 vs LIQT's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -116.2% | -46.7% | +52.9% | -70.0% |
| ROA (TTM)Return on assets | -94.4% | -21.7% | +13.2% | -29.5% |
| ROICReturn on invested capital | -27.1% | -27.1% | +22.2% | -31.1% |
| ROCEReturn on capital employed | -39.5% | -38.0% | +26.8% | — |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.08x | 0.50x | 42.14x | 1.17x |
| Net DebtTotal debt minus cash | $2M | $8M | $506M | $12M |
| Cash & Equiv.Liquid assets | $261,355 | $2M | $75M | — |
| Total DebtShort + long-term debt | $2M | $10M | $580M | $12M |
| Interest CoverageEBIT ÷ Interest expense | -11.83x | -52.63x | 5.95x | -13.46x |
Total Returns (Dividends Reinvested)
CCSI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCSI five years ago would be worth $7,940 today (with dividends reinvested), compared to $0 for PAVS. Over the past 12 months, LIQT leads with a +64.8% total return vs PAVS's -99.9%. The 3-year compound annual growth rate (CAGR) favors CCSI at -7.9% vs PAVS's -93.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -94.8% | -6.8% | +30.2% | +54.9% |
| 1-Year ReturnPast 12 months | -99.9% | -78.3% | +26.8% | +64.8% |
| 3-Year ReturnCumulative with dividends | -100.0% | -99.3% | -21.8% | -31.3% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.9% | -20.6% | -96.1% |
| 10-Year ReturnCumulative with dividends | -100.0% | -99.9% | -20.6% | -90.9% |
| CAGR (3Y)Annualised 3-year return | -93.2% | -80.9% | -7.9% | -11.8% |
Risk & Volatility
Evenly matched — CCSI and LIQT each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIQT is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than TAOP's 2.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCSI currently trades 89.3% from its 52-week high vs PAVS's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.51x | 2.30x | 1.51x | 0.52x |
| 52-Week HighHighest price in past year | $1488.00 | $20.10 | $31.66 | $3.35 |
| 52-Week LowLowest price in past year | $1.02 | $1.18 | $19.24 | $1.30 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +6.4% | +89.3% | +68.9% |
| RSI (14)Momentum oscillator 0–100 | 31.9 | 53.1 | 51.0 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 20K | 123K | 50K |
Analyst Outlook
Evenly matched — TAOP and CCSI each lead in 1 of 1 comparable metric.
Analyst Outlook
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — |
| Price TargetConsensus 12-month target | — | — | $25.00 | — |
| # AnalystsCovering analysts | — | — | 6 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 1 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.4% | 0.0% |
CCSI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PAVS leads in 1 (Valuation Metrics). 2 tied.
PAVS vs TAOP vs CCSI vs LIQT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PAVS or TAOP or CCSI or LIQT a better buy right now?
For growth investors, LiqTech International, Inc.
(LIQT) is the stronger pick with 13. 0% revenue growth year-over-year, versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). Consensus Cloud Solutions, Inc. (CCSI) offers the better valuation at 6. 5x trailing P/E (5. 0x forward), making it the more compelling value choice. Analysts rate Consensus Cloud Solutions, Inc. (CCSI) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PAVS or TAOP or CCSI or LIQT?
On forward P/E, Paranovus Entertainment Technology Ltd.
is actually cheaper at 0. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PAVS or TAOP or CCSI or LIQT?
Over the past 5 years, Consensus Cloud Solutions, Inc.
(CCSI) delivered a total return of -20. 6%, compared to -100. 0% for Paranovus Entertainment Technology Ltd. (PAVS). Over 10 years, the gap is even starker: CCSI returned -20. 6% versus PAVS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PAVS or TAOP or CCSI or LIQT?
By beta (market sensitivity over 5 years), LiqTech International, Inc.
(LIQT) is the lower-risk stock at 0. 52β versus Taoping Inc. 's 2. 30β — meaning TAOP is approximately 339% more volatile than LIQT relative to the S&P 500. On balance sheet safety, Paranovus Entertainment Technology Ltd. (PAVS) carries a lower debt/equity ratio of 8% versus 42% for Consensus Cloud Solutions, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PAVS or TAOP or CCSI or LIQT?
By revenue growth (latest reported year), LiqTech International, Inc.
(LIQT) is pulling ahead at 13. 0% versus -98. 9% for Paranovus Entertainment Technology Ltd. (PAVS). On earnings-per-share growth, the picture is similar: Paranovus Entertainment Technology Ltd. grew EPS 96. 4% year-over-year, compared to -1870. 0% for Taoping Inc.. Over a 3-year CAGR, TAOP leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PAVS or TAOP or CCSI or LIQT?
Consensus Cloud Solutions, Inc.
(CCSI) is the more profitable company, earning 24. 2% net margin versus -110. 3% for Paranovus Entertainment Technology Ltd. — meaning it keeps 24. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCSI leads at 43. 0% versus -94. 8% for PAVS. At the gross margin level — before operating expenses — CCSI leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PAVS or TAOP or CCSI or LIQT more undervalued right now?
On forward earnings alone, Paranovus Entertainment Technology Ltd.
(PAVS) trades at 0. 0x forward P/E versus 5. 0x for Consensus Cloud Solutions, Inc. — 5. 0x cheaper on a one-year earnings basis.
08Which pays a better dividend — PAVS or TAOP or CCSI or LIQT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is PAVS or TAOP or CCSI or LIQT better for a retirement portfolio?
For long-horizon retirement investors, LiqTech International, Inc.
(LIQT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 52)). Taoping Inc. (TAOP) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIQT: -90. 9%, TAOP: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PAVS and TAOP and CCSI and LIQT?
These companies operate in different sectors (PAVS (Consumer Defensive) and TAOP (Technology) and CCSI (Technology) and LIQT (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PAVS is a small-cap quality compounder stock; TAOP is a small-cap quality compounder stock; CCSI is a small-cap deep-value stock; LIQT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.